Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Cardiac Allograft Vasculopathy (CAV) by Optical Coherence Tomography (OCT)

NCT02503566 is registered in ClinicalTrials.gov with Institute for Clinical and Experimental Medicine as lead sponsor.

NCT NCT02503566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02503566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Cardiac Allograft Vasculopathy (CAV) by Optical Coherence Tomography (OCT)
Lead sponsor
Institute for Clinical and Experimental Medicine
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2014
Completion date
June 1, 2019
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

disorder related to cardiac transplantation